Skip to main content
OpenTrials
Completed

NCT Number: NCT00576329

Topical 0.4% Ketorolac and Vitreoretinal Surgery

To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Surgery Eye Diseases Mydriasis Pupil Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Emory Eye Clinic

Atlanta, Georgia, 30322, United States

About this study

Other outcomes will be to assess postoperative pain and inflammation and visual acuity.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age of 18, routine elective vitrectomy

Exclusion criteria

  • history of trauma, uveitis, prior intraocular surgery within 3 months, requirement of mechanical pupil dilation, prior inclusion of other eye

Treatment and study plan

Ketorolac

Drug

Topical use before surgery

Other names: Acular LS

Primary outcomes

  1. Change in pupil size during vitreoretinal surgery

    Time frame: Surgery

Secondary outcomes

  1. Postoperative pain and inflammation

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

Emory University

Other

Registry information

Official study title

Topical 0.4% Ketorolac for the Inhibition of Miosis During Vitreoretinal Surgery: a Randomized, Placebo-controlled, Double-masked Study

Important dates

Study start
2006
Study completion
2007
First posted
Dec 19, 2007
Registry last updated
May 14, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.